Activity
-
After 39 years of being in business on the Peninsula, the time has come to close the doors at Studio V Hair Salon in San Carlos. In2011, amidst…
After 39 years of being in business on the Peninsula, the time has come to close the doors at Studio V Hair Salon in San Carlos. In2011, amidst…
Liked by Alithea Zetter
-
Today we announced that we have entered into a definitive agreement under which Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will acquire…
Today we announced that we have entered into a definitive agreement under which Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will acquire…
Liked by Alithea Zetter
-
In honor of #PresidentsDay, we want to take a moment to honor our past leaders and reflect on America’s foundational values.
In honor of #PresidentsDay, we want to take a moment to honor our past leaders and reflect on America’s foundational values.
Liked by Alithea Zetter
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
More activity by Alithea
-
We’re #hiring for a new Associate Director/Director, Clinical Operations in Seattle, Washington or remote. Apply today or share this job with your…
We’re #hiring for a new Associate Director/Director, Clinical Operations in Seattle, Washington or remote. Apply today or share this job with your…
Liked by Alithea Zetter
-
Beyond positions and titles, it's the respect we give that truly defines our professional legacy. __________ 🚀 I help CEOs organically grow their…
Beyond positions and titles, it's the respect we give that truly defines our professional legacy. __________ 🚀 I help CEOs organically grow their…
Liked by Alithea Zetter
-
We dropped the fees, and College of San Mateo is free! Your pathway to a new career is possible and easier than ever! No fees. No tuition. No debt…
We dropped the fees, and College of San Mateo is free! Your pathway to a new career is possible and easier than ever! No fees. No tuition. No debt…
Liked by Alithea Zetter
-
What makes a great leader? Someone who helps their team maximize their gifts and potential to become the very best version of themselves. That’s…
What makes a great leader? Someone who helps their team maximize their gifts and potential to become the very best version of themselves. That’s…
Liked by Alithea Zetter
-
We dropped the fees, and now College of San Mateo is free! Your pathway to a new career is possible and easier than ever! No fees. No tuition. No…
We dropped the fees, and now College of San Mateo is free! Your pathway to a new career is possible and easier than ever! No fees. No tuition. No…
Liked by Alithea Zetter
Explore more posts
-
Los Angeles Biotech Networks
Latest on MDMA rejection; Novo vs. Lilly earnings; Recursion, Exscientia to merge; Q&A with Genentech CEO; and more https://lnkd.in/gRuf3XRp Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up [...] #LosAngeles #OrangeCountyCA #Biotech #Lifescience #News
-
Lynx.MD
🌐 The Lynx.MD team is heading to San Diego for DIA 2024. Drug discovery is a complex, lengthy process. DIA brings together the life sciences community to discuss innovations accelerating advancements, bringing therapies to care faster. Reach out to the Lynx.MD team, including Collin Labar, on LinkedIn to learn more about how our partners are using Lynx.MD’s rich structured and unstructured data sets to find insights addressing medical affairs and market access. See you at #DIA2024! 🌟 #Data #Research
-
Ian Schacht
Phenomenal news: Ractigen Announces Positive Clinical Data for RAG-17 in ALS-SOD1 Treatment from Investigator-Initiated Trial. From the new release "Encouragingly, early signs of clinical benefit were also evident. Notable changes in clinical outcomes and key biomarkers indicate the efficacy of RAG-17 within this patient population. These positive clinical findings align with Ractigen's robust preclinical data, which demonstrated significant therapeutic effects of RAG-17 in SOD1-G93A ALS mouse and rat models, including delayed disease progression and improved survival." We are making great strides in helping patients with ALS-SOD1 mutation. #ALS #SOD1 #IIT https://lnkd.in/gq4Vha6m
-
Inizio Evoke
Are you attending #BIO2024 today in San Diego? If you’ll be there, make sure to pop by for our session where our Executive Biotech Advisor, Carin Canale-Theakston, will share "An Insider Look at Top Deals from 2023” at 3pm-4pm PST. The session offers valuable insights into biotech collaborations and innovations. Looking forward to seeing old friends and making new connections at the conference today! #Biotech #InvestorRelations #LifeSciences #CorpComms #InizioEvokeComms
1 Comment
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More